PROK Competitors & Alternatives
Compare ProKidney Corp. with similar stocks in the same industry
Biotechnology
PROK
Main Stock$2.03
Tradestie Score
57
Market Cap
$350.98M
Revenue Growth
0.0%
Analyst Upside
+207.9%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ERAS
Erasca, Inc. Common Stock
|
$18.47
|
$626.91M | - | 60 | Compare |
|
SVRA
Savara Inc.
|
$6.22
|
$611.84M | - | 64 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.82
|
$552.46M | - | 58 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$15.23
|
$540.97M | - | 55 | Compare |
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$9.69
|
$533.99M | - | 55 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.98
|
$529.35M | 6.9 | 62 | Compare |
|
OCGN
Ocugen, Inc. Common Stock
|
$1.51
|
$524.67M | - | 57 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$97.79
|
$522.78M | - | 56 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.32
|
$512.39M | - | 59 | Compare |
More PROK Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2836)
235 stocks in this industry